SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-004626
Filing Date
2018-04-03
Accepted
2018-04-03 06:07:56
Documents
100
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2487565
2 ex23-1.htm EX-23.1 3494
3 ex31-1.htm EX-31.1 19139
4 ex31-2.htm EX-31.2 11305
5 ex32-1.htm EX-32.1 4810
6 ex32-2.htm EX-32.2 4823
  Complete submission text file 0001493152-18-004626.txt   7477669

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE aker-20171231.xml EX-101.INS 1046278
8 XBRL SCHEMA FILE aker-20171231.xsd EX-101.SCH 77792
9 XBRL CALCULATION FILE aker-20171231_cal.xml EX-101.CAL 78966
10 XBRL DEFINITION FILE aker-20171231_def.xml EX-101.DEF 307862
11 XBRL LABEL FILE aker-20171231_lab.xml EX-101.LAB 518695
12 XBRL PRESENTATION FILE aker-20171231_pre.xml EX-101.PRE 436216
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 18731222
SIC: 2835 In Vitro & In Vivo Diagnostic Substances